500mg Mesalamine DR

MESALMILE 500 PR 
Mesalamine DR (500mg)
Mesalamine Delayed Release (DR) tablets are a formulation of mesalamine, also known as 5-aminosalicylic acid (5-ASA), used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The delayed-release formulation allows for the controlled release of the active ingredient in the gastrointestinal tract.

The typical dosage of MESALMILE 500 PR  tablets is 500 mg taken orally three times a day. However, the specific dosing regimen can vary depending on the individual's condition, the severity of symptoms, and the guidance of the prescribing healthcare provider.

It is important to follow the dosing instructions provided by your healthcare provider or the information on the medication label. Taking the tablets with food or as directed by your doctor can help optimize absorption and minimize gastrointestinal side effects.

Common side effects of MESALMILE 500 PR  may include nausea, abdominal pain, diarrhea, headache, and allergic reactions. If you experience severe or persistent side effects, it is important to seek medical attention.

Please keep in mind that I am an AI language model and not a healthcare professional. Therefore, it is always recommended to consult with your healthcare provider or pharmacist for personalized medical advice and information regarding your specific condition and the appropriate use of Mesalamine Delayed Release tablets.
For further information please contact:
contact@sterispharma.com
order now sterisonline.com